HORIZON EUROPE | HYDROHEAL PROGRESS MEETING
HYDROHEAL innovates with hydrogel formulations to address bone strength challenges by treating vertebral and alveolar fractures.
June 10, 2026
HYDROHEAL innovates with hydrogel formulations to address bone strength challenges by treating vertebral and alveolar fractures.
Last month, our colleagues Sergio Veiga and Marta Rayo represented ASPHALION at the Nabiheal Consortium Meeting, where project partners came
Last week in Siena, we joined the partners of the IMMUTOL project for its 3rd Annual Meeting
We are proud to share that the KeratoPrinter project was featured at the RAPS EuroConvergence 2026. During
Within the EU-funded ETERNAL project, where Asphalion serves as the regulatory partner, supporting the consortium to ensure
At Asphalion, we’re excited to be part of key events, conferences, and summits throughout 2026—great opportunities to connect, exchange insights, and collaborate with leaders across healthcare and medical devices.
Corneal blindness affects over 11.7 million people worldwide, yet only 1 in 70 patients receive a corneal transplant due to a severe donor shortage. The KeratOPrinter project aims to address this gap by developing a groundbreaking 4D bioprinting suite capable of producing fully functional, biocompatible human corneas. Combining expertise from world-class partners, the project focuses on scalable cell sources, advanced bioinks, high-precision bioprinting, clinical handling solutions, regulatory compliance, and a strong collaborative network. By 2035, KeratOPrinter seeks to revolutionize corneal transplantation and restore vision for millions.
Within the EU-funded ETERNAL project, where Asphalion serves as the regulatory partner, supporting the consortium to ensure
Search or filter
Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts.
We will be happy to assist you!
